Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wilson Tang

Showing results (271-280 of 1,044) with videos related to

Pageof 105
Sort By:
JACC. Heart Failure|January 4, 2023
Reply: Racial and Genetic Differences: Possible Health Disparities in Transthyretin Amyloid Cardiomyopathy Patients?Trejeeve Martyn, Joshua Saef, Rola Khedraki, et al.
International Journal of Cardiology|January 22, 2017
Cardiovascular impact in patients undergoing maintenance hemodialysis: Clinical management considerationsSrisakul Chirakarnjanakorn, Sankar D Navaneethan, Gary S Francis, et al.
Nature Medicine|September 5, 2024
Reply to Guyton, J. R. & Boden, W. E.; Schreiber, S. et alW H Wilson Tang, Joseph A DiDonato, Hooman Allayee, et al.
The American Journal of Cardiology|July 28, 2012
Relation of systemic and urinary neutrophil gelatinase-associated lipocalin levels to different aspects of impaired renal function in patients with acute decompensated heart failureKevin Shrestha, Zhili Shao, Dhssraj Singh, et al.
Journal of Cardiovascular Development and Disease|February 24, 2023
Ciclopirox Inhibition of eIF5A Hypusination Attenuates Fibroblast Activation and Cardiac FibrosisKadiam C Venkata Subbaiah, Jiangbin Wu, Wai Hong Wilson Tang, et al.
Circulation. Heart Failure|March 14, 2025
Hereditary Transthyretin Cardiac Amyloidosis With the p.V142I Variant: Mechanistic Insights and Diagnostic ChallengesSimon Vanhentenrijk, Justin L Grodin, Silvio Nunes Augusto, et al.
JACC. Heart Failure|June 3, 2017
Patients Not Meeting PARADIGM-HF Enrollment Criteria Are Eligible for Sacubitril/Valsartan on the Basis of FDA Approval: The Need to Close the GapAntonio L Perez, Veraprapas Kittipibul, W H Wilson Tang, et al.
JACC. Heart Failure|June 30, 2023
Distinct Impact of Noncardiac Comorbidities on Exercise Capacity and Functional Status in Chronic Heart FailurePieter Martens, Silvio N Augusto, J Emanuel Finet, et al.
JCI Insight|June 7, 2022
FAM114A1 influences cardiac pathological remodeling by regulating angiotensin II signalingKadiam C Venkata Subbaiah, Jiangbin Wu, Wai Hong Wilson Tang, et al.
Clinical and Translational Science|October 28, 2011
Cellular proliferative response to cardiac troponin-I in patients with idiopathic dilated cardiomyopathyJason M Lappé, Clara M Pelfrey, Anne Cotleur, et al.
Pageof 105

Showing results (271-280 of 1,044) with videos related to

Sort By:
Pageof 105
JACC. Heart Failure|January 4, 2023
Reply: Racial and Genetic Differences: Possible Health Disparities in Transthyretin Amyloid Cardiomyopathy Patients?Trejeeve Martyn, Joshua Saef, Rola Khedraki, et al.
International Journal of Cardiology|January 22, 2017
Cardiovascular impact in patients undergoing maintenance hemodialysis: Clinical management considerationsSrisakul Chirakarnjanakorn, Sankar D Navaneethan, Gary S Francis, et al.
Nature Medicine|September 5, 2024
Reply to Guyton, J. R. & Boden, W. E.; Schreiber, S. et alW H Wilson Tang, Joseph A DiDonato, Hooman Allayee, et al.
The American Journal of Cardiology|July 28, 2012
Relation of systemic and urinary neutrophil gelatinase-associated lipocalin levels to different aspects of impaired renal function in patients with acute decompensated heart failureKevin Shrestha, Zhili Shao, Dhssraj Singh, et al.
Journal of Cardiovascular Development and Disease|February 24, 2023
Ciclopirox Inhibition of eIF5A Hypusination Attenuates Fibroblast Activation and Cardiac FibrosisKadiam C Venkata Subbaiah, Jiangbin Wu, Wai Hong Wilson Tang, et al.
Circulation. Heart Failure|March 14, 2025
Hereditary Transthyretin Cardiac Amyloidosis With the p.V142I Variant: Mechanistic Insights and Diagnostic ChallengesSimon Vanhentenrijk, Justin L Grodin, Silvio Nunes Augusto, et al.
JACC. Heart Failure|June 3, 2017
Patients Not Meeting PARADIGM-HF Enrollment Criteria Are Eligible for Sacubitril/Valsartan on the Basis of FDA Approval: The Need to Close the GapAntonio L Perez, Veraprapas Kittipibul, W H Wilson Tang, et al.
JACC. Heart Failure|June 30, 2023
Distinct Impact of Noncardiac Comorbidities on Exercise Capacity and Functional Status in Chronic Heart FailurePieter Martens, Silvio N Augusto, J Emanuel Finet, et al.
JCI Insight|June 7, 2022
FAM114A1 influences cardiac pathological remodeling by regulating angiotensin II signalingKadiam C Venkata Subbaiah, Jiangbin Wu, Wai Hong Wilson Tang, et al.
Clinical and Translational Science|October 28, 2011
Cellular proliferative response to cardiac troponin-I in patients with idiopathic dilated cardiomyopathyJason M Lappé, Clara M Pelfrey, Anne Cotleur, et al.
Pageof 105